SCHEMBL13480262

SCHEMBL13480262

CCc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)N(CC)CCN(CC)CC

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 15/20 0.65
PDGFRB P09619 10/20 0.65
PRKAA1 Q13131 8/20 0.65
PRKAA2 P54646 7/20 0.65
KIT P10721 5/20 0.65
FGFR1 P11362 4/20 0.65
FLT3 P36888 3/20 0.65
CSF1R P07333 3/20 0.65
EGFR P00533 3/20 0.65
PLK4 O00444 2/20 0.65
DCLK1 O15075 2/20 0.65
PDPK1 O15530 2/20 0.65
DAPK3 O43293 2/20 0.65
ROCK2 O75116 2/20 0.65
RPS6KA5 O75582 2/20 0.65
RPS6KA4 O75676 2/20 0.65
MAP4K4 O95819 2/20 0.65
CHEK2 O96017 2/20 0.65
NTRK1 P04629 2/20 0.65
INSR P06213 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19862518 0.86 KDR (0.71) KDRPDGFRBPRKAA1PRKAA2KIT
SCHEMBL15459745 0.83 KDR (0.74) KDRPDGFRBPRKAA1PRKAA2KIT
SCHEMBL13480222 0.83 FLT3 (0.67) KDRPDGFRBPRKAA1PRKAA2KIT
SCHEMBL28430169 0.83 KDR (0.74) KDRPDGFRBPRKAA1PRKAA2KIT
SCHEMBL9961043 0.82 KDR (0.72) KDRPDGFRBPRKAA1PRKAA2KIT
SCHEMBL16569473 0.82 KDR (0.72) KDRPDGFRBPRKAA1PRKAA2KIT
SCHEMBL9961038 0.81 KDR (0.71) KDRPDGFRBPRKAA1PRKAA2KIT
SCHEMBL25600982 0.81 KDR (0.71) KDRPDGFRBPRKAA1PRKAA2KIT
SCHEMBL9961042 0.81 KDR (0.71) KDRPDGFRBPRKAA1PRKAA2KIT
SCHEMBL28428856 0.80 KDR (0.83) KDRPDGFRBPRKAA1PRKAA2KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2157093-A1 PYRROLO-NITROGENOUS HETEROCYCLIC DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF Shanghai Hengrui Pharmaceutical Co. Ltd. (CN) 2010-02-24 EP disclosed